Shuttle Pharmaceuticals Inc (SHPH): Today SHPH reached new bottom at $3, now...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	205
Posts	23870
Boards Moderated	0
Alias Born	01/06/2005

konshe

Re: splintered sunlight post# 107

Thursday, 10/13/2022 2:38:17 PM

Thursday, October 13, 2022 2:38:17 PM

Today SHPH reached new bottom at $3, now traded at 3.40, looks like its bottom out. From here it will rebound for sure. Its easy to back to IPO price $8.125. if new drag begin to be produced and got patent from URUP, then PPS will fly again.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SHPH News

Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 10:16:10 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 10:01:32 PM
Shuttle Pharma Provides Third Quarter 2024 Corporate Update • GlobeNewswire Inc. • 11/13/2024 10:00:21 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/30/2024 04:15:07 AM
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 10/30/2024 01:05:52 AM
Shuttle Pharma Pays Off Senior Secured Convertible Note • GlobeNewswire Inc. • 10/29/2024 08:05:00 PM
Micro Cap Company Is Soaring On Phase 2 Trial Update • AllPennyStocks.com • 10/29/2024 04:55:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 01:00:26 PM
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma • GlobeNewswire Inc. • 10/29/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2024 08:05:10 PM
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma • GlobeNewswire Inc. • 10/28/2024 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2024 01:00:39 PM
Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024 • GlobeNewswire Inc. • 10/28/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2024 12:52:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 09:17:59 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2024 09:00:06 PM
Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma • GlobeNewswire Inc. • 09/16/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 09:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 09:23:05 PM
Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease • GlobeNewswire Inc. • 09/05/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 08:26:42 PM
Shuttle Pharma Provides Second Quarter 2024 Corporate Update • GlobeNewswire Inc. • 09/04/2024 08:15:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/04/2024 01:54:28 AM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 09/04/2024 01:52:57 AM

More SHPH News

InvestorsHub NewsWire

North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • NBRI • Nov 18, 2024 9:00 AM

One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM

Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM

HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM

Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM

Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover